PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNeos Therapeutics
Neos Therapeutics(NEOS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AdzenysAmphetamine2017-09-152024-2038
Narcolepsy
,
Attention deficit disorder with hyperactivity
CotemplaMethylphenidate2017-06-192024-2038
Narcolepsy
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
Hydrocodone polistirex chlorpheniramne polistirexChlorpheniramine polistirex, Hydrocodone polistirex2012-06-292025-2035
Pain
,
Fever
,
Postoperative pain
,
Obstructive lung diseases
,
Cough
,
Inflammation
,
Juvenile arthritis
,
Menorrhagia
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Bursitis
,
Dysmenorrhea
,
Gout
,
Premenstrual syndrome
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Obesity
,
Urinary incontinence
,
Rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Rheumatic fever
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Methylphenidate
hyperkinesis
,
attention deficit disorder with hyperactivity
Aspartame
hyperkinesis
,
attention deficit disorder with hyperactivity
Nt0102
hyperkinesis
,
attention deficit disorder with hyperactivity
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use